Financiera Confianza S.A.A. (BVL:FCONFIC1)

Intercept Pharmaceuticals Cash Flow Statement

Financials in millions PEN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	31.17	12.7	12.02	42.81	3.16	14.26
Depreciation & Amortization	12.4	12.13	9.36	7.42	7.12	8.88
Provision for Credit Losses	153.93	153.93	157.42	91.3	122.85	120.97
Change in Accounts Payable	28.81	-5.73	-27.94	15.28	-7.09	5.22
Change in Other Net Operating Assets	-348.32	-134.17	-285.75	-243.88	-95.7	-296.04
Other Operating Activities	39.91	3.55	-23.98	11.17	-25.33	-11.24
Operating Cash Flow	-82.11	42.41	-158.88	-75.9	5.01	-157.97
Capital Expenditures	0.16	-3.09	-8.09	-2.62	-1.99	-3.86
Sale of Property, Plant and Equipment	0.19	0.19	1.33	-	-	0.02
Investment in Securities	20.73	-	-	-	-	-
Purchase / Sale of Intangibles	-10.81	-10.81	-13.26	-7.83	-1.66	-2.03
Investing Cash Flow	-20.3	-13.71	-20.02	-10.45	-3.64	-5.87
Long-Term Debt Issued	-	-	202.77	144.05	-	3.97
Long-Term Debt Repaid	-	-120.45	-	-	-11.18	-
Net Debt Issued (Repaid)	-120.45	-120.45	202.77	144.05	-11.18	3.97
Common Dividends Paid	-5.46	-5.41	-19.27	-	-	-
Net Increase (Decrease) in Deposit Accounts	125	125	-2.01	21.12	-189.77	395.9
Other Financing Activities	195.22	-	-	-	-	-
Financing Cash Flow	194.3	-0.86	181.5	165.17	-200.95	399.87
Net Cash Flow	91.9	27.83	2.61	78.81	-199.58	236.04
Free Cash Flow	-81.95	39.32	-166.97	-78.52	3.03	-161.82
Free Cash Flow Margin	-25.16%	13.53%	-56.86%	-25.68%	1.32%	-64.14%
Free Cash Flow Per Share	-15.25	7.30	-30.98	-14.57	0.56	-30.03
Cash Income Tax Paid	-	-	-	-	-	18.5

Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.